Oltea Sampetrean
机构: Project Professor / Administrative Director, Keio University Bio2Q
主页: keio.ac.jp
每年引用次数
引用次数
引用: 1,784
H-指数: 24
I10-指数 : 36
出版物: 102
A Three-Dimensional Invasion Assay for Glioma-Initiating Cells in a Microfluidic Device
Shingo Fujioka , Sampetrean Oltea , Hideyuki Saya , Ryo Sudo
Transactions of Japanese Society for Medical and Biological Engineering 51
2013
Mitotic regulation and carcinogenesis
Hideyuki Saya , Dongwei Zhang , Sampetrean Oltea ,
Tanpakushitsu kakusan koso. Protein nucleic acid enzyme 54 561 -567
2009
A microfluidic invasion assay for glioma-initiating cells in three-dimensional culture
Shingo Fujioka , Sampetrean Oltea , Hideyuki Saya , Ryo Sudo
17th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2013 2 1075 -1077
2013
Defective system-level regulation of Aurora B underlies chromosome instability in cancers
Minji Jo , Sampetrean Oltea , Hideyuki Saya , Toru Hirota
CANCER SCIENCE 109 896 -896
2018
Role of p38 MAP kinase in cell death induced by anti-cancer drugs
Hideyuki Saya , Shin-ichi Iida , Sampetrean Oltea ,
JOURNAL OF PHARMACOLOGICAL SCIENCES 103 17P -17P
2007
Endovascular surgery as the first-choice treatment for ruptured cerebral aneurysms: how far has it come?
O. Tone , H. Tomita , M. Tamaki , Y. Satoh
Interventional Neuroradiology 10 41 -47
1
2004
Coil Embolization for Ruptured Cerebral Aneurysms of 2×3 mm Diameter
O. Tone , H. Tomita , M. Tamaki , H. Akimoto
Interventional Neuroradiology 12 ( 1_suppl) 97 -100
2006
INTEGRATED ANALYSIS IDENTIFIES DIFFERENT METABOLIC SIGNATURES WITHIN BOTH TUMOR-INITIATING CELLS AND STEM CELLS IN A MURINE GLIOBLASTOMA MODEL
O. Sampetrean , H. Saya
Neuro-oncology 16
2014
CB-04EPIGENETIC REGULATION OF GLIOBLASTOMA TUMORIGENICITY: A HYBRID MODEL
F. Furnari , H. Matsui , O. Harismendy , W. Cavenee
Neuro-oncology 16
2014
Characterization of a novel BBB-permeable mutant IDH1 inhibitor, DS-1001b
H. Matsunaga , Y. Machida , M. Nakagawa , M. Yamaguchi
Annals of Oncology 30
2019
Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model
I. Saga , S. Shibao , J. Okubo , S. Osuka
Neuro-oncology 16 ( 8) 1048 -1056
31
2014
LAB-STEM CELLS
D. Kozono , M. Nitta , O. Sampetrean , N. Kimberly
Neuro-oncology 14 142 -152
1
2012
[Endosaccular embolization of an intrasellar aneurysm with hypopituitarism: case report].
Osamu Tone , Hiroki Tomita , Masashi Tamaki , Mutsumi Fujii
No shinkei geka. Neurological surgery 36 ( 4) 329 -337
4
2008
p53 mutations in brain tumors
Yusuke Maeda , Oltea Sampetrean , Hideyuki Saya ,
Nihon rinsho. Japanese journal of clinical medicine 112 -116
2016
MEK inhibition preferentially suppresses anchorage‐independent growth in osteosarcoma cells and decreases tumors in vivo
Hideyuki Saya , Oltea Sampetrean , Eiji Sugihara , Eiji Sugihara
Journal of Orthopaedic Research
2021
N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.
Satoru Osuka , Dan Zhu , Zhaobin Zhang , Chaoxi Li
Journal of Clinical Investigation 131 ( 6)
27
2021
Lactate Reprograms Energy and Lipid Metabolism in Glucose-Deprived Oxidative Glioma Stem Cells.
Hideyuki Saya , Oltea Sampetrean , Takashi Sasayama , Noriaki Minami
Metabolites 11 ( 5) 325
2021
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model.
Yukino Machida , Makoto Nakagawa , Hironori Matsunaga , Masayuki Yamaguchi
Molecular Cancer Therapeutics 19 ( 2) 375 -383
4
2020
2-Nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche.
Naoyoshi Koike , Ryuichi Kota , Yoshiko Naito , Noriyo Hayakawa
Communications Biology 3 ( 1) 450
22
2020
In Vitro Blood–Brain Barrier Permeability and Cytotoxicity of an Atorvastatin-Loaded Nanoformulation Against Glioblastoma in 2D and 3D Models
Michael M. Lübtow , Sabrina Oerter , Sabina Quader , Elisabeth Jeanclos
Molecular Pharmaceutics 17 ( 6) 1835 -1847
5
2020